Does UPADACITINIB Cause Squamous cell carcinoma? 107 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Squamous cell carcinoma have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
107
Reports of Squamous cell carcinoma with UPADACITINIB
0.2%
of all UPADACITINIB reports
2
Deaths
13
Hospitalizations
How Dangerous Is Squamous cell carcinoma From UPADACITINIB?
Of the 107 reports, 2 (1.9%) resulted in death, 13 (12.1%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 107 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which UPADACITINIB Alternatives Have Lower Squamous cell carcinoma Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL